How Paul Manafort’s Plans Backfired

In early 2021, a Wikipedia editor peered into the future and saw what looked like a funnel cloud on the horizon: the rise of GPT-3, a precursor to the new chatbots from OpenAI. When this editor — a prolific Wikipedian who goes by the handle Barkeep49 on the site — gave the new technology a try, he could see that it was untrustworthy. The bot would readily mix fictional elements (a false name, a false academic citation) into otherwise factual and coherent answers. But he had no doubts about its potential. “I think A.I.’s day of writing a high-quality encyclopedia is coming sooner rather than later,” he wrote in “Death of Wikipedia,” an essay that he posted under his handle on Wikipedia itself. He speculated that a computerized model could, in time, displace his beloved website and its human editors, just as Wikipedia had supplanted the Encyclopaedia Britannica, which in 2012 announced it was discontinuing its print publication.Recently, when I asked this editor if he still worried about his encyclopedia’s fate, he told me that the newer versions made him more convinced that ChatGPT was a threat. “It wouldn’t surprise me if things are fine for the next three years,” he said of Wikipedia, “and then, all of a sudden, in Year 4 or 5, things drop off a cliff.”This story was recorded by Audm. To hear more audio stories from publications like The New York Times, download Audm for iPhone or Android. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

10 Sep 202351min

This episode contains descriptions of severe injuries. Last week, a devastating fire swept through a derelict building in Johannesburg that housed desperate families who had no place else to go. The authorities had been repeatedly warned that it was a potential firetrap. Nothing was done, and at least 76 people died.Lynsey Chutel, who covers southern Africa for The Times, explains how Johannesburg, once a symbol of the hope of post-apartheid South Africa, became an emblem of just how bad the country’s breakdown has become.Guest: Lynsey Chutel, a southern Africa correspondent for The New York Times.Background reading: An extensive paper trail revealed that the authorities in Johannesburg were warned repeatedly about the dangers in the building that burned down.Johannesburg, with a severe shortage of affordable housing, has hundreds of illegally occupied derelict buildings that officials and housing advocates say have become firetraps.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

8 Sep 202331min

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.Rebecca Robbins, who covers the pharmaceutical industry for The Times, discusses one man’s case and how patents can create perverse incentives to delay new and better drugs.Guest: Rebecca Robbins, a business reporter covering the pharmaceutical industry for The New York Times.Background reading: Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents showed.In August, an expert panel recommended the new daily pill Descovy for H.I.V. prevention.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

7 Sep 202335min

In New York, the arrival of more than 100,000 migrants seeking asylum over the past year has become a crisis for the city’s shelter system, schools and budget.As another critical election season begins to take shape, Nicholas Fandos, who covers New York State politics for The Times, explains why the situation has also become a political crisis for the state’s Democratic leaders.Guest: Nicholas Fandos, a reporter covering New York State politics for The New York Times Metro desk.Background reading: New York’s migrant crisis is growing. So are Democrats’ anxieties.A scathing letter revealed tension among New York Democrats over the city’s migrant crisis.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

6 Sep 202328min

A Times investigation found that U.S. passenger planes come dangerously close to crashing into each other far more frequently than the public knows.Sydney Ember, an economics reporter for The Times, explains why an aviation system known for its safety is producing such a steady stream of close calls.Guest: Sydney Ember, an economics correspondent for The New York Times.Background reading: Airline close calls happen far more often than previously known.What you need to know about turbulence.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

5 Sep 202328min

A Times investigation revealed that in much of the United States, communities and farms are pumping out groundwater at alarming rates. Aquifers are shrinking nationwide, threatening supplies of drinking water and the country’s status as a food superpower.Christopher Flavelle, who covers climate adaptation for The Times, went to Arizona, the state at the forefront of the crisis, and looked at one especially controversial idea to address it: desalination.Guest: Christopher Flavelle covers climate adaptation for The New York Times.Background reading: America is using up its groundwater like there’s no tomorrow.Five takeaways from the investigation into the groundwater crisis.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

1 Sep 202339min

A year ago, Congress overhauled the way drugs for older Americans get paid for, by giving Medicare the power to bargain with drug makers over prices in the biggest change to health care for more than a decade. This week, the Biden administration began its implementation.Sheryl Gay Stolberg, who covers health policy for The Times, discusses the decades long battle for bargaining power and Rebecca Robbins, who covers the pharmaceutical industry for The Times, explains its potential to reshape the business of drugs in America.Guest: Sheryl Gay Stolberg, a Washington correspondent covering health policy for The New York Times.Rebecca Robbins, a business reporter for The New York Times covering the pharmaceutical industry.Background reading: The Biden administration announced a long-awaited list of the first 10 medicines that will be subject to price negotiations with Medicare.Drugmakers are “throwing the kitchen sink” to halt Medicare price negotiations.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

31 Aug 202332min

In the Republican presidential race, the battle for second place has been jolted by the sudden rise of a political newcomer whose popularity has already eclipsed that of far more seasoned candidates — Vivek Ramaswamy.Jonathan Weisman, who is a political correspondent for The Times, explains the rising candidate’s back story, message and strategy.Guest: Jonathan Weisman, a political correspondent for The New York Times.Background reading: Surging poll numbers underscore that Vivek Ramaswamy is having a well-timed political moment.Mr. Ramaswamy, a millennial, has a lot to say about his generation.For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

30 Aug 202328min